MIDATECH PHARMA
Investors | Shareholder information
Shareholder Meeting Notices
Date Title Document Webcast
13/08/2018 Notice of 2018 AGM
28/09/2017 Notice of General Meeting to be held on 16 October 2017
11/04/2017 Notice of Annual General Meeting 2017
12/10/2016 Notice of General Meeting to be held on 28 October 2016
11/05/2016 Notice of 2016 AGM
21/05/2015 Notice of 2015 AGM
Share Detail
Number of shares 61,084,135
Country of listing UK / US
Status AIM Listed / NASDAQ Listed
Index FTSE AIM All Share / NASDAQ
FTSE Sector Pharmaceutical & Biotechnology
FTSE sub-sector Biotechnology
Ticker MTPH / MTP

The percentage of 0.005p Ordinary shares not being held in public hands is 80.9%

Shares held in treasury: Nil 0.005p Ordinary shares.

There are no restrictions on the transfer of Ordinary shares in the Company.

Information correct as at 7 June 2018

Major shareholders
Midatech Pharma has been notified or is aware of the following holdings of more than 3% or more of the issued share capital of the Company.
Name Number of shares %
Woodford Investment Management 12,247,629 20.1
Legal & General Group

10,275,518

16.8
City Financial 3,650,000 6.0
Wings Establishment 3,043,164 5.0
Hargreave Hale 2,866,632 4.7
     
Midatech Pharma Share Incentive Plan 111,340 n/a

Information correct as at 7 June 2018

ADR Information
Ticker Structure Exchange Ratio DR ISIN CUSIP
MTP Level III ADR NASDAQ 1 ADR : 2 Ordinary Shares US59564R1041 59564R104
Investors
Shareholder information
© Copyright 2018 Midatech Pharma PLC